Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 33,454 shares, an increase of 1,608.6% from the October 15th total of 1,958 shares. Approximately 2.7% of the company’s stock are sold short. Based on an average daily trading volume, of 18,461 shares, the days-to-cover ratio is presently 1.8 days.
Institutional Investors Weigh In On Global X HealthTech ETF
A number of institutional investors have recently added to or reduced their stakes in HEAL. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its stake in shares of Global X HealthTech ETF by 28.3% in the 3rd quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 195,122 shares of the company’s stock valued at $5,758,000 after purchasing an additional 43,075 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Global X HealthTech ETF by 4.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 23,037 shares of the company’s stock worth $680,000 after buying an additional 950 shares during the period. Finally, Royal Bank of Canada raised its position in shares of Global X HealthTech ETF by 39.4% during the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after acquiring an additional 736 shares during the last quarter.
Global X HealthTech ETF Trading Down 1.4%
NASDAQ HEAL traded down $0.44 during trading on Thursday, reaching $30.49. The company’s stock had a trading volume of 5,055 shares, compared to its average volume of 10,819. The stock has a market capitalization of $37.81 million, a PE ratio of 28.10 and a beta of 1.13. The business has a 50-day moving average price of $29.87 and a 200-day moving average price of $27.33. Global X HealthTech ETF has a 1-year low of $23.00 and a 1-year high of $32.15.
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
See Also
- Five stocks we like better than Global X HealthTech ETF
- If Japan’s Stock Market Rally Returns, These 3 ETFs Could Benefit
- CoreWeave’s Backlog Is Surging—Can the Stock Follow?
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
